Correlation Between Recursion Pharmaceuticals and 06051GFC8

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 06051GFC8 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 06051GFC8 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and BANK AMER P, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 06051GFC8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 06051GFC8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 06051GFC8.

Diversification Opportunities for Recursion Pharmaceuticals and 06051GFC8

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Recursion and 06051GFC8 is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and BANK AMER P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BANK AMER P and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 06051GFC8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BANK AMER P has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 06051GFC8 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 06051GFC8

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 6.65 times more return on investment than 06051GFC8. However, Recursion Pharmaceuticals is 6.65 times more volatile than BANK AMER P. It trades about 0.06 of its potential returns per unit of risk. BANK AMER P is currently generating about -0.12 per unit of risk. If you would invest  672.00  in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  64.00  from holding Recursion Pharmaceuticals or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy93.02%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  BANK AMER P

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
BANK AMER P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BANK AMER P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for BANK AMER P investors.

Recursion Pharmaceuticals and 06051GFC8 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and 06051GFC8

The main advantage of trading using opposite Recursion Pharmaceuticals and 06051GFC8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 06051GFC8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 06051GFC8 will offset losses from the drop in 06051GFC8's long position.
The idea behind Recursion Pharmaceuticals and BANK AMER P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world